The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma.
about
The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma.Return to work for patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation.Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry.Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma.Quality of life after chemotherapy or hematopoietic cell transplant in follicular lymphoma: what's next?
P2860
The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The impact of high-dose chemot ...... vors with follicular lymphoma.
@en
The impact of high-dose chemot ...... vors with follicular lymphoma.
@nl
type
label
The impact of high-dose chemot ...... vors with follicular lymphoma.
@en
The impact of high-dose chemot ...... vors with follicular lymphoma.
@nl
prefLabel
The impact of high-dose chemot ...... vors with follicular lymphoma.
@en
The impact of high-dose chemot ...... vors with follicular lymphoma.
@nl
P2093
P2860
P1433
P1476
The impact of high-dose chemot ...... vors with follicular lymphoma.
@en
P2093
Anthony D Ho
Juliane Brandt
Marie-Luise Memmer
Sascha Dietrich
Silke Andresen
P2860
P304
P356
10.3109/10428194.2011.613132
P577
2011-10-10T00:00:00Z